“Non-Interference” And Part D: Prescriber Oversight Is Focus Of CMS Final Rule
This article was originally published in RPM Report
Executive Summary
CMS’ final rule on Part D is much narrower than the agency’s proposed rule—and most in industry are probably pleased by that. But it is also much more one-sided, emphasizing new tools to monitor for and correct “abusive” prescribing, without any countervailing provisions reflecting the value of appropriate medication adherence.
You may also be interested in...
Medication Therapy Management: The Gap Between Theory And Practice
US Medicare Payment Advisory Commission still sees promise in ‘Medication Therapy Management’ programs. But why is the value of enhanced pharmacy support for patients on complex prescription regimens so hard to prove in actual practice?
Class Warfare: CMS Proposes Sweeping Changes to Part D; “Protected Class” Cuts Just the Start
The Centers for Medicare & Medicaid Services is celebrating the 10th anniversary of Part D by proposing the most sweeping changes to the Medicare drug benefit since it launched. Proposed revisions to the “Protected Classes” will get the most attention, but the rest of the rule may have more profound impacts going forward.
So That's What "Non-Interference" Means: CMS Defines Loaded Term in Proposed Part D Rule
The 700-page Part D proposed rule does much more than change the "protected" class list. Among many other provisions, it spells out how CMS interprets the infamous "non-interference" clause.